Author

A. G. Robertson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

M. A. A. Castro· 2 shared A. de Reynies· 1 shared A. Hartmann· 1 shared A. Kamoun· 1 shared A. Obajemu· 1 shared A. R. Banday· 1 shared A. Zlotta· 1 shared C. P. Dinney· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. A. A. Castro

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

IFN-{lambda}4 may contribute to HCV persistence by increasing ER stress and enhancing IRF1 signaling

O. O. Onabajo, F. Wang, M.-H. Lee, O. Florez-Vargas, A. Obajemu, M. A. A. Castro, C. Tanikawa, J. Vargas, S.-F. Liao, C. Song, Y.-H. Huang, C.-Y. Shen, A. R. Banday, T. R. O'Brien, Z. Hu, , L. Prokunina-Olsson

This study investigates the association between IFNL4 genetic variants and HCV-related cirrhosis and HCC risk, finding protective effects against cirrhosis and increased HCC risk in specific populations.

bioRxiv · Oct 28, 2020 · PreprintCancer Biology

A consensus molecular classification of muscle-invasive bladder cancer

A. Kamoun, A. de Reynies, Y. Allory, G. Sjodahl, A. G. Robertson, R. Seiler, K. Hoadley, H. Al-Ahmadie, W. Choi, C. S. Groeneveld, M. A. A. Castro, J. Fontugne, P. Eriksson, Q. Mo, J. Kardos, , The Bladder Cancer Molecular Taxonomy Group

The paper identifies six consensus molecular classes of muscle-invasive bladder cancer using transcriptomic data and classification systems, providing a framework for future biomarker validation.

bioRxiv · Apr 27, 2019Cancer Biology